We are live on
!
Find out more
QF
QVT Financial Portfolio holdings
AUM
$1.37B
1-Year Est. Return
148.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.17%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.8B
AUM Growth
-$205M
(-10%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
54.4%
Holding
111
New
19
Increased
11
Reduced
29
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arbutus Biopharma
ABUS
|
+$328M |
| 2 |
Anterix
ATEX
|
+$36.7M |
| 3 |
JD.com
JD
|
+$28.2M |
| 4 |
ONIT
Onity Group
ONIT
|
+$25.6M |
| 5 |
Trip.com Group
TCOM
|
+$18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$123M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$121M |
| 3 |
AGEN
Agenus
AGEN
|
+$28.5M |
| 4 |
Tenet Healthcare
THC
|
+$28.4M |
| 5 |
YPF
YPF
|
+$26.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.05% |
| 2 | Consumer Discretionary | 9.81% |
| 3 | Financials | 5.26% |
| 4 | Real Estate | 2.9% |
| 5 | Communication Services | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $293M | 16.32% |
+3,900,000
| New | +$272M |
|
|
2
Arbutus Biopharma
ABUS
$865M
| $280M | 15.57% |
+16,013,540
| New | +$328M |
|
|
LL
3
PUT
DELISTED
LL Flooring Holdings, Inc.
LL
| $64.8M | 3.61% |
2,105,200
-834,800
| -28% | -$42.7M |
|
4
eBay
EBAY
$48.6B
| $46.4M | 2.58% |
1,909,952
-59,163
| -3% | -$1.41M |
|
|
5
Anterix
ATEX
$1.83B
| $32.6M | 1.81% |
+754,916
| New | +$36.7M |
|
6
MakeMyTrip
MMYT
$4.67B
| $31.9M | 1.78% |
1,454,913
-160,000
| -10% | -$3.89M |
|
|
SCTY
7
PUT
DELISTED
SolarCity Corporation
SCTY
| $31.1M | 1.73% |
+606,000
| New | +$31.1M |
|
|
8
JD.com
JD
$40.8B
| $30.8M | 1.72% |
+1,049,100
| New | +$28.2M |
|
|
XLRN
9
DELISTED
Acceleron Pharma
XLRN
| $29M | 1.61% |
761,661
-200,556
| -21% | -$7.98M |
|
|
10
Tenet Healthcare
THC
$20.1B
| $27.1M | 1.51% |
547,085
-608,305
| -53% | -$28.4M |
|
|
ONIT
11
Onity Group
ONIT
$333M
| $25.7M | 1.43% |
207,732
+191,399
| +1,172% | +$25.6M |
|
12
Navigator Holdings
NVGS
$1.34B
| $23.1M | 1.29% |
1,210,300
+176,400
| +17% | +$3.18M |
|
|
13
Trip.com Group
TCOM
$27.5B
| $21.8M | 1.21% |
+744,292
| New | +$18M |
|
14
Capital One
COF
$124B
| $21.4M | 1.19% |
271,824
+85,059
| +46% | +$6.68M |
|
|
HOUS
15
DELISTED
Anywhere Real Estate
HOUS
| $19.7M | 1.1% |
434,240
-37,760
| -8% | -$1.74M |
|
|
AGEN
16
Agenus
AGEN
$249M
| $18.8M | 1.05% |
186,626
-285,133
| -60% | -$28.5M |
|
|
NRF
17
DELISTED
NorthStar Realty Finance Corp.
NRF
| $18.3M | 1.02% |
506,000
-281,484
| -36% | -$10.4M |
|
|
CYTR
18
DELISTED
CytRx Corp
CYTR
| $17.8M | 0.99% |
879,198
+21,937
| +3% | +$408K |
|
|
LL
19
DELISTED
LL Flooring Holdings, Inc.
LL
| $17.5M | 0.97% |
567,882
-173,666
| -23% | -$8.88M |
|
|
SCTY
20
DELISTED
SolarCity Corporation
SCTY
| $17.4M | 0.97% |
+338,416
| New | +$17.4M |
|
21
PUT
Canadian Solar
CSIQ
$906M
| $16.7M | 0.93% |
+500,000
| New | +$13.8M |
|
|
ANAC
22
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $16.5M | 0.92% |
284,383
-89,570
| -24% | -$3.8M |
|
23
Iovance Biotherapeutics
IOVA
$2.23B
| $16M | 0.89% |
+1,325,000
| New | +$14.9M |
|
|
EPZM
24
DELISTED
Epizyme, Inc
EPZM
| $15.6M | 0.87% |
831,000
-112,200
| -12% | -$2.32M |
|
|
ONIT
25
PUT
Onity Group
ONIT
$333M
| $15.1M | 0.84% |
121,920
-8,667
| -7% | -$1.16M |
|
Similar funds
KRS
AF
PGP
DC
FC
PP
MAWA
SOS
QVT Financial's Q1 2015 Portfolio in Review
As of Q1 2015, QVT Financial held 111 positions worth $1.8B, down 10% from $2B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
QVT Financial withdrew a net $127M in Q1 2015, closing 32 positions and reducing 29 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, QVT Financial opened a new position in Arbutus Biopharma worth $280M.
- QVT Financial's largest Q1 2015 buy was Arbutus Biopharma: 16,013,540 shares worth $280M.
- QVT Financial added most to Onity Group in Q1 2015, an estimated $25.6M increase.
- QVT Financial's biggest Q1 2015 reduction was Agenus, cutting an estimated $28.5M.
- QVT Financial fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $123M.
- QVT Financial's ten largest holdings make up 54% of its $1.8B portfolio in Q1 2015.
- QVT Financial opened 19 new positions and closed 32 in Q1 2015.
- QVT Financial's portfolio value fell 10% quarter-over-quarter to $1.8B.
Based on QVT Financial's 13F filing for Q1 2015, filed 15 May 2015.